Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the US. Participants experienced an average weight loss of 7.2 kg with the 36 mg ...

Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Executive order on prescription drug pricing supports key drug industry efforts to weaken the Medicare negotiation program.

Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...

A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug.

When it comes to oral semaglutide, the OASIS-1 trial showed that it led to a 15.1% reduction in body weight. But this was at ...